Insomnia Market, By Therapy Type (Pharmacological Therapy and Non Pharmacological Therapy), By Drug Formulation (Capsules and Tablets), By Type of Diseases (Poor Quality of Sleep and Sleep Maintenance), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI23919 | Publish Date: March 2024 | No. of Pages: 178

Global Insomnia Market By Therapy Overview

Insomnia is a disorder characterized by lack of sleep or inability to sleep. People with insomnia often experience fatigue, low energy, difficulty concentrating, mood disturbances, and decreased performance overall. Insomnia-related conditions are caused due to disruption in circadian rhythm, chronic pain, hyperthyroidism, menopause, and psychological stress. Excessive use of drugs, such as caffeine, alcohol, and nicotine could also lead to insomnia.Insomnia Market accounted for US$ 2.76 billion in 2020 and is estimated to be US$ 4.62 billion by 2030 and is anticipated to register a CAGR of 5.0%.

Global Insomnia Market By Therapy Dynamics

Surging number of insomnia patient

Surging number of insomnia patient across the globe is the primary factor driving the market. Technological advances in the treatment drugs are also fuelling the target market growth currently. In addition, increasing number of people working in shifts and stressful conditions is also supporting the global market growth.

Lack of education and awareness

However, lack of education and awareness about the disorder is a major restraining factor for the growth of the market. Factors like presence of large undiagnosed insomnia population pool and untapped markets in developing economies present lucrative opportunities for the market growth.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Insomnia Market By Therapy Segmentation

Insomnia market has been segmented into therapy type drug formulation, and region.

On the basis of therapy type, insomnia market has been bifurcated into pharmacological therapy and non-pharmacological therapy. Non-pharmacological therapy is further segmented into hypnotherapy, cognitive behavioral therapy, medical devices, and other non-pharmacological therapy. Pharmacological therapy is further segmented into prescription sleep aids and over-the-counter sleep aids. Based on drug formulation, target market is classified into capsules and tablets. According to type of disease, global market is segmented into poor quality of sleep and sleep maintenance.

Regional Insights:

Based on region, the insomnia market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America region is dominating the global market as it accounts for the highest percentage of insomnia-affected patients among all regions. North America market is followed by Europe, owing to increasing stress among the population in these regions. Asia-Pacific, Middle East, and Africa markets are anticipated to have the least target market growth over the forecast period.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By Therapy Type: Pharmacological Therapy and Non Pharmacological Therapy

By Drug Formulation: Capsules and Tablets

By Type of Diseases: Poor Quality of Sleep and Sleep Maintenance

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Detailed Segmentation:

Insomnia Market, By Region:

  • North America
    • Middle East & Africa
      • Middle East & Africa Insomnia Market, By Therapy Type
      • Middle East & Africa Insomnia Market, By Drug Formulation
      • Middle East & Africa Insomnia Market, By Type of Disease
      • Middle East & Africa Insomnia Market, By Country
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
      • Latin America Insomnia Market, By Therapy Type
      • Latin America Insomnia Market, By Drug Formulation
      • Latin America Insomnia Market, By Type of Disease
      • Latin America Insomnia Market, By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
      • Asia Pacific Insomnia Market, By Therapy Type
      • Asia Pacific Insomnia Market, By Drug Formulation
      • Asia Pacific Insomnia Market, By Type of Disease
      • Asia Pacific Insomnia Market, By Country
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
      • Europe Insomnia Market, By Therapy Type
      • Europe Insomnia Market, By Drug Formulation
      • Europe Insomnia Market, By Type of Disease
      • Europe Insomnia Market, By Country
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • North America Insomnia Market, By Therapy Type
    • North America Insomnia Market, By Drug Formulation
    • North America Insomnia Market, By Type of Disease
    • North America Insomnia Market, By Country
      • The U.S.
      • Canada

Global Insomnia Market By Therapy Key Players

Key players operating in the insomnia market include Eisai, Co., Pfizer, Inc., Merck & Co Inc., Sanofi SA, Takeda Pharmaceutical Company, Meda Consumer Healthcare Inc., Pernix Therapeutics, Purdue Pharma L.P., Consumer Healthcare Inc., and Dainippon Sumitomo Pharma Ltd.

Global Insomnia Market By Therapy Company Profile

  • Eisai, Co.
    • Dainippon Sumitomo Pharma Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Consumer Healthcare Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Purdue Pharma L.P.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Pernix Therapeutics
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Meda Consumer Healthcare Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Takeda Pharmaceutical Company
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Sanofi SA
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Merck & Co Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Pfizer, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance

Global Insomnia Market By Therapy Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for Insomnia Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Therapy Type
      • Market Snippet, By Drug Formulation
      • Market Snippet, By Type of Disease
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation , By Therapy Type,  2020 – 2030, (US$ Mn)
    • Overview                          
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Pharmacological Therapy
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Non-Pharmacological Therapy
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Market Segmentation , By Drug Formulation,  2020 – 2030, (US$ Mn)
    • Overview                
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Capsules
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Tablets
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. , By Type of Disease, 2020 – 2030, (US$ Mn)
    • Overview                   
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Poor Quality of Sleep
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Sleep Maintenance
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Market , By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Therapy Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Drug Formulation, Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type of Disease, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Therapy Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Drug Formulation, Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type of Disease, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Therapy Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Drug Formulation, Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type of Disease, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Therapy Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Drug Formulation, Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type of Disease, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Therapy Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Drug Formulation, Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type of Disease, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
      •  
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
  •  
    • Dainippon Sumitomo Pharma Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Consumer Healthcare Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Purdue Pharma L.P.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Pernix Therapeutics
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Meda Consumer Healthcare Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Takeda Pharmaceutical Company
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Sanofi SA
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Merck & Co Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Pfizer, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Eisai, Co.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

The Last Word

  •  
    • Future Impact
    • About Us
    • Contact

FAQs

The insomnia market has been segmented into therapy type drug formulation, and region.

Surging number of insomnia patient across the globe is the primary factor driving the market.

North America region is dominating the market as it accounts for the highest percentage of insomnia-affected patients among all regions.

Key players operating in the insomnia market include Eisai, Co., Pfizer, Inc., Merck & Co Inc., Sanofi SA, Takeda Pharmaceutical Company, Meda Consumer Healthcare Inc., Pernix Therapeutics, Purdue Pharma L.P., Consumer Healthcare Inc., and Dainippon Sumitomo Pharma Ltd.